A Reuters analysis found four of the nation’s top 10 drugs increased more than 100 percent since 2011. Six others went up more than 50 percent, and together these increases added billions in costs across payers and consumers.
Read the full article here.
"Patients would be better served if drug prices reflected value, instead of bargaining power."